Narin Osman Selected Research

Narin Osman Research Topics

Disease

28	Atherosclerosis 11/2022 - 01/2005
6	Cardiovascular Diseases (Cardiovascular Disease) 02/2015 - 01/2005
3	Hyperglycemia 12/2010 - 05/2006
3	Hypertension (High Blood Pressure) 12/2008 - 05/2006
2	Inflammation (Inflammations) 02/2024 - 01/2007
2	Atherosclerotic Plaque (Atheroma) 01/2016 - 05/2014
2	Macular Degeneration (Age-Related Maculopathy) 01/2016 - 01/2016
2	Vascular Diseases (Vascular Disease) 02/2015 - 12/2010
2	Insulin Resistance 03/2008 - 05/2006
1	Diabetes Mellitus 02/2024
1	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2024
1	Hypercalcemia (Milk Alkali Syndrome) 02/2024
1	Amyloidosis 01/2019
1	Wounds and Injuries (Trauma) 01/2018
1	Melanoma (Melanoma, Malignant) 07/2017
1	Pathologic Processes 01/2016
1	Stroke (Strokes) 01/2016
1	Streptococcal Infections (Streptococcal Infection) 01/2016
1	Myocardial Infarction 01/2016
1	Neointima 03/2013
1	Aortic Valve Disease 03/2013
1	Type 2 Diabetes Mellitus (MODY) 03/2008
1	Hypertriglyceridemia 01/2007
1	Hypercholesterolemia 01/2007
1	Dyslipidemias (Dyslipidemia) 05/2006

Drug/Important Bio-Agent (IBA)

25	Proteoglycans (Proteoglycan)IBA 11/2022 - 01/2005
15	LipidsIBA 11/2022 - 01/2007
10	GlycosaminoglycansIBA 01/2019 - 01/2005
7	Lipoproteins (Lipoprotein)IBA 01/2019 - 01/2005
7	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018 - 03/2008
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 05/2006
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 12/2010
4	BiglycanIBA 01/2018 - 10/2008
4	Platelet-Derived Growth FactorIBA 05/2014 - 11/2008
3	Thrombin FDA Link 01/2019 - 03/2013
3	Phosphotransferases (Kinase)IBA 01/2018 - 08/2008
2	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 05/2006
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2016
2	tyrosine receptor (receptor, tyrosine)IBA 07/2017 - 08/2008
2	ApolipoproteinsIBA 01/2016 - 05/2014
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2014 - 04/2013
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2008 - 07/2008
2	Endothelin-1 (Endothelin 1)IBA 08/2008 - 07/2008
2	Peptides (Polypeptides)IBA 08/2008 - 07/2008
2	oxidized low density lipoproteinIBA 03/2008 - 01/2007
1	Silicon Dioxide (Silica)FDA LinkGeneric 02/2024
1	Retinaldehyde (Retinal)IBA 02/2024
1	Calcitriol (Calcijex)FDA LinkGeneric 02/2024
1	Vitamin D FDA LinkGeneric 02/2024
1	25-hydroxyvitamin DIBA 02/2024
1	Dextrans (Dextran)FDA Link 02/2024
1	AcidsIBA 02/2024
1	Plasminogen Activator Inhibitor 1IBA 01/2018
1	galactosaminoglycanIBA 01/2018
1	TOR Serine-Threonine KinasesIBA 07/2017
1	VemurafenibIBA 07/2017
1	Anti-Infective Agents (Microbicides)IBA 01/2016
1	Fusidic Acid (Fucithalmic)IBA 01/2016
1	EnzymesIBA 01/2016
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 02/2015
1	IsomerasesIBA 02/2015
1	gingerolIBA 07/2013
1	S 6 (S-6)IBA 07/2013
1	Endothelins (Endothelin)IBA 04/2013
1	Tyrosine (L-Tyrosine)FDA Link 04/2013
1	A-factor (Streptomyces)IBA 12/2010
1	Serine (L-Serine)FDA Link 08/2010
1	Threonine (L-Threonine)FDA Link 08/2010
1	Growth Factor ReceptorsIBA 08/2010
1	low density lipoprotein inhibitorIBA 06/2010
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2010
1	DecorinIBA 01/2010
1	Dermatan SulfateIBA 08/2009
1	ChondroitinIBA 08/2009
1	p38 Mitogen-Activated Protein KinasesIBA 12/2008
1	N- (4- methyl- 3- ((4- pyridin- 3- ylpyrimidin- 2- yl)amino)phenyl)- N'- phenylureaIBA 11/2008
1	dermatan sulfate proteoglycanIBA 10/2008
1	rho-Associated KinasesIBA 08/2008
1	Type C PhospholipasesIBA 08/2008
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 08/2008
1	beta-ArrestinsIBA 08/2008
1	Mitogen-Activated Protein KinasesIBA 08/2008
1	Amino Acids FDA Link 07/2008
1	Hormones (Hormone)IBA 07/2008
1	Complement System Proteins (Complement)IBA 07/2008
1	2,4-thiazolidinedione (thiazolidinedione)IBA 03/2008
1	Advanced Glycation End ProductsIBA 01/2007
1	Insulin (Novolin)FDA Link 05/2006
1	Insulin ReceptorIBA 05/2006
1	AndrogensIBA 07/2005
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2005
1	Antihypertensive Agents (Antihypertensives)IBA 01/2005

Therapy/Procedure

4	Therapeutics 12/2008 - 01/2005
1	RNAi Therapeutics 01/2019